Stratipath aims to radically improve clinical decision-making and therapeutic outcomes for cancer patients using novel and cost-effective AI-based diagnostics.
Using real-world, large population datasets to deliver clinically validated AI-based models, we can optimise clinical information to go beyond current routine pathology-based diagnostics, improving cancer treatment decision making and patient outcomes.
Our approach offers improved clinical precision, and a reduction in diagnostic errors in healthcare and provides an accelerated path for pharma and biotech companies to identify patients most likely to benefit from novel therapies.